Steward Partners Investment Advisory’s Haemonetics HAE Stock Holding History

Steward Partners Investment Advisory’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,138	Closed	-$91.2K	–	4494
2025 Q4	$91.2K	Sell	1,138 -92	-7%	-$6.18K	﹤0.01%	2351
2025 Q3	$60K	Sell	1,230 -134	-10%	-$8.29K	﹤0.01%	2514
2025 Q2	$102K	Buy	1,364 +111	+9%	+$7.35K	﹤0.01%	2108
2025 Q1	$79.6K	Buy	1,253 +226	+22%	+$15.4K	﹤0.01%	2146
2024 Q4	$80.2K	Buy	+1,027	New	+$82.5K	﹤0.01%	2093
2021 Q4	–	Sell	-32	Closed	-$2K	–	3232
2021 Q3	$2K	Hold	32	–	–	﹤0.01%	2986
2021 Q2	$2K	Hold	32	–	–	﹤0.01%	6871
2021 Q1	$3.55K	Buy	+32	New	+$3.96K	﹤0.01%	3094
2019 Q3	–	Sell	-755	Closed	-$90K	–	2674
2019 Q2	$90K	Buy	+755	New	+$74.3K	﹤0.01%	1099

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Steward Partners Investment Advisory's HAE Position: Q1 2026 in Review

Steward Partners Investment Advisory sold out of Haemonetics (HAE) in Q1 2026, closing a stake of 1,138 shares — an estimated $91.2K sold.

Steward Partners Investment Advisory first reported a position in HAE in Q2 2019 and held it in 9 quarters. The position peaked at $102K in Q2 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

Steward Partners Investment Advisory reported no remaining Haemonetics position as of Q1 2026 after selling out during the quarter.
Steward Partners Investment Advisory sold 1,138 Haemonetics shares in Q1 2026, an estimated $91.2K.
Steward Partners Investment Advisory first reported a position in Haemonetics in Q2 2019 and held it in 9 quarters.
Steward Partners Investment Advisory's Haemonetics position peaked at $102K in Q2 2025.
324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.